H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection
H1抗组胺药可降低乙型肝炎病毒、丙型肝炎病毒或乙型肝炎病毒-丙型肝炎病毒双重感染患者发生肝细胞癌的风险。
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.21.01802
Shen, Yu-Chuan; Hsu, Hui-Ching; Lin, Tzu-Min; Chang, Yu-Sheng; Hu, Li-Fang; Chen, Lung-Fang; Lin, Sheng-Hong; Kuo, Pei-I; Chen, Wei-Sheng; Lin, Yi-Chun; Chen, Jin-Hua; Liang, Yu-Chih; Chang, Chi-Ching